Enzyme inhibitors

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Enzyme inhibitors

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Enzyme inhibitors (lat. inhibere 'stop') are endogenous or exogenous substances that bind to specific enzymes and suppress or slow down their metabolic reactions. In most cases, the enzyme itself is altered by binding in such a way that it becomes functionless. Enzyme inhibitors can dock competitively or non-competitively at different sites of an enzyme (e.g. active centre, allosteric centre) and inhibit these reversibly or irreversibly (see belowenzyme inhibition). Many inhibitors are analogues of the natural substrate.

ClassificationThis section has been translated automatically.

A large number of drugs belong to the group of enzyme inhibitors. Examples of medicinal enzyme inhibitors are

  • ACE inhibitors: ACE inhibitors block the angiotensin converting enzyme. This enzyme catalyzes the formation of angiotensin II from angiotensin I. Thus, the effects of angiotensin II are cancelled. The blood pressure is lowered.
  • Non-steroidal anti-inflammatory drugs (NSAID): This group of substances reversibly inhibits cyclooxygenases and thus the prostaglandin synthesis.
  • Cholinesterase inhibitors (indirect parasympathomimetics such as physostigmine inhibit the enzymatic degradation of acetylcholine by cholinesterases)
  • Reverse transcriptase inhibitors (RTI) such as ziduvidin, which inhibit the transcription of viral RNA into DNA during HIV infection.
  • Protease inhibitors such as indinavir, which inhibit the catalytic function of HIV protease. This leads to HIV particles with immature morphology
  • Xanthine oxidase inhibitors (gout therapeutics such as allopurinol which prevent the conversion of hypoxanthine to uric acid by competitively inhibiting xanthine oxidase)
  • Proton pump inhibitors (substances such as omaprazole which selectively inhibit the H+/K+-ATPase in the lining cells of the stomach mucosa (proton pump).

Authors

Last updated on: 29.10.2020